Increasing evidence has highlighted the involvement of SLC proteins in cancer biology, where they contribute to tumor progression, metabolic reprogramming, immune evasion, and therapeutic resistance (Wu et al., 2021). The gene discussed is CCL21; the disease is neoplasm.